Neurosurgery 37 , 733741 (1995)
doi:10.1056/NEJMoa1411481
Ali FA, Pulido LA, Garza MN, Amerson MH, Greenhill B, Brown KN, Lim SK, Manyam VR, Nguyen HN, Prudhomme CC, Regan LE, Sims WR, Umeh AU, Williams R, Tillman PK, Hu PC
The availability of Wegovy pill expands the possibilities for weight management with semaglutide, giving healthcare professionals a powerful, efficacious medicine in a new method of delivery, allowing the ability to help meet more patients where they are. While longer-term data and real-world evidence will be important to define where Wegovy tablets fit relative to injectables, the FDAs decision underscores how GLP-1 medicines continue to redefine expectations around medical weight management and reshape how obesity is treated.
First, as a retrospective observational analysis, the cohort is subject to healthy subject treatment bias
If you have ever had preeclampsia, it becomes another risk factor for the development of vascular disease, even 20 to 30 years down the road, said Dr